Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Read more
RNA therapeutics is at a critical stage following the success of the COVID-19 mRNA vaccines Read more
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton Syndrome Read more
Novartis India Limited extends access to its medicines in India by signing exclusive sales and distribution agreement with Dr. Reddy’s Laboratories Read more
Moderna Announces New Supply Agreement with Colombia for Additional 10.8 Million Doses of Moderna’s COVID-19 Vaccine Read more
AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus Read more